Therefore, the suppression of PI3K/AKT pathway by ISL in our study more strongly supports the results from previous researches, and it also proves that ISL can play a role as a natural PI3K inhibitor in HCC treatment. This evidence concerns the gene AKT1 and hepatocellular carcinoma.